Advancing Rotavirus Vaccine Development (ARVAC) - BBIL Phase 3 Study
PATH?s Advancing Rotavirus Vaccine Development (ARVAC) project, the Indian Department of Biotechnology (DBT), and Bharat Biotech International, Ltd. (BBIL) conducted a Phase 3 efficacy study of BBILs 116E (ROTAVAC®) rotavirus vaccine, and an Expanded Program on Immunization (EPI) non?interference...